Pathios Therapeutics Limited
10641754
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 27/02/2017
COMPANY DIRECTOR
AUSTRALIAN · UNITED KINGDOM · Age 59
Also on 2 other boards
director · Since 28/08/2019
VENTURE CAPITAL INVESTOR
AMERICAN · UNITED STATES · Age 63
Also on 1 other board
secretary · Since 15/06/2022
director · Since 14/07/2025
BIOTECH DRUG DEVELOPMENT
AMERICAN · UNITED STATES · Age 64
Persons with Significant Control
Former PSCs
Dr Someit Singh Sidhu
Ceased 29/10/2018
Canaan Xi L.P.
Ceased 28/08/2019
CompanyRankvs 135+ SIC 72110 peers82
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£4.8M
Balance sheet strength
Cash
£3.3M
Cash in the bank
Net Current Assets
£4.1M
Working capital
Current Assets
£4.7M
Current Liabilities
£677k
Fixed Assets
£782k
Debtors
£1.5M
Profit After Tax
-£6.1M
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 7.00 | +£1.1M |
| 2023 | 6.35 | -£421k |
| 2022 | 6.09 | +£628k |
| 2020 | 8.86 | +£712k |
| 2019 | 29.19 | +£2.6M |
| 2018 | 3.38 | — |
Derived from filed accounts. Not audited figures.